Characteristics of participants
. | Control . | Myocardial infarction . | Ischemic stroke . | Non-MI ischemic heart disease . | |||
---|---|---|---|---|---|---|---|
CCHS . | Patients . | CCHS . | Patients . | CCHS . | Patients . | CCHS . | |
No. of individuals | 7907 | 493 | 469 | 231 | 410 | 448 | 365 |
Age, y | 56 ± 0.2 | 58 ± 0.4* | 68 ± 0.4‡ | 63 ± 0.5‡ | 69 ± 0.4‡ | 58 ± 0.5* | 69 ± 0.5‡ |
Body mass index, kg/m2 | 25.5 ± 0.05 | 26.4 ± 0.2‡ | 26.7 ± 0.2‡ | 25.5 ± 0.3 | 26.1 ± 0.2‡ | 26.4 ± 0.2‡ | 26.5 ± 0.2‡ |
Cholesterol, mM | 6.1 ± 0.01 | 6.2 ± 0.06 | 6.6 ± 0.05‡ | 6.5 ± 0.08‡ | 6.5 ± 0.06‡ | 6.3 ± 0.06† | 6.4 ± 0.07‡ |
HDL cholesterol, mM | 1.6 ± 0.01 | 1.1 ± 0.02‡ | 1.4 ± 0.02‡ | 1.4 ± 0.03‡ | 1.5 ± 0.02‡ | 1.2 ± 0.02‡ | 1.5 ± 0.03† |
Lipoprotein(a), mg/L | 300 ± 4 | 621 ± 29‡ | 397 ± 20* | 442 ± 41† | 361 ± 22 | 573 ± 30‡ | 334 ± 20 |
Triglycerides, mM | 1.8 ± 0.02 | 2.4 ± 0.1‡ | 2.4 ± 0.1‡ | 2.3 ± 0.1‡ | 2.2 ± 0.1‡ | 2.2 ± 0.1‡ | 2.2 ± 0.1‡ |
Fibrinogen, mg/dL | 3.0 ± 0.01 | — | 3.6 ± 0.04‡ | — | 3.5 ± 0.04‡ | — | 3.5 ± 0.05‡ |
Women, % | 57 | 20‡ | 36‡ | 39‡ | 48‡ | 33‡ | 46‡ |
Smoking, % | 73 | 88‡ | 84‡ | 80* | 80† | 76 | 82‡ |
Hypertension, % | 17 | 31‡ | 35‡ | 46‡ | 40‡ | 29‡ | 35‡ |
Diabetes mellitus, % | 3 | 11‡ | 9‡ | 14‡ | 8‡ | 9‡ | 6‡ |
. | Control . | Myocardial infarction . | Ischemic stroke . | Non-MI ischemic heart disease . | |||
---|---|---|---|---|---|---|---|
CCHS . | Patients . | CCHS . | Patients . | CCHS . | Patients . | CCHS . | |
No. of individuals | 7907 | 493 | 469 | 231 | 410 | 448 | 365 |
Age, y | 56 ± 0.2 | 58 ± 0.4* | 68 ± 0.4‡ | 63 ± 0.5‡ | 69 ± 0.4‡ | 58 ± 0.5* | 69 ± 0.5‡ |
Body mass index, kg/m2 | 25.5 ± 0.05 | 26.4 ± 0.2‡ | 26.7 ± 0.2‡ | 25.5 ± 0.3 | 26.1 ± 0.2‡ | 26.4 ± 0.2‡ | 26.5 ± 0.2‡ |
Cholesterol, mM | 6.1 ± 0.01 | 6.2 ± 0.06 | 6.6 ± 0.05‡ | 6.5 ± 0.08‡ | 6.5 ± 0.06‡ | 6.3 ± 0.06† | 6.4 ± 0.07‡ |
HDL cholesterol, mM | 1.6 ± 0.01 | 1.1 ± 0.02‡ | 1.4 ± 0.02‡ | 1.4 ± 0.03‡ | 1.5 ± 0.02‡ | 1.2 ± 0.02‡ | 1.5 ± 0.03† |
Lipoprotein(a), mg/L | 300 ± 4 | 621 ± 29‡ | 397 ± 20* | 442 ± 41† | 361 ± 22 | 573 ± 30‡ | 334 ± 20 |
Triglycerides, mM | 1.8 ± 0.02 | 2.4 ± 0.1‡ | 2.4 ± 0.1‡ | 2.3 ± 0.1‡ | 2.2 ± 0.1‡ | 2.2 ± 0.1‡ | 2.2 ± 0.1‡ |
Fibrinogen, mg/dL | 3.0 ± 0.01 | — | 3.6 ± 0.04‡ | — | 3.5 ± 0.04‡ | — | 3.5 ± 0.05‡ |
Women, % | 57 | 20‡ | 36‡ | 39‡ | 48‡ | 33‡ | 46‡ |
Smoking, % | 73 | 88‡ | 84‡ | 80* | 80† | 76 | 82‡ |
Hypertension, % | 17 | 31‡ | 35‡ | 46‡ | 40‡ | 29‡ | 35‡ |
Diabetes mellitus, % | 3 | 11‡ | 9‡ | 14‡ | 8‡ | 9‡ | 6‡ |